| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | COO &Cbo
1 company
Nash Huw M. is a Chief Business Officer at Stoke Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $1K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2024 | STOK Stoke Therapeutics, Inc. | Chief Business Officer | Sell | 2,500 | $13.11 | $32,778.87 | -98.7% | -4.2% | -10.0% | |
| May 20, 2024 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 50,000 | $15.39 | $769,500.00 | -100% | -7.8% | -37.6% | |
| Apr 1, 2024 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 61,329 | $13.23 | $811,211.75 | -99.4% | +2.8% | -53.8% | |
| Mar 19, 2024 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 4,116 | $6.10 | $25,101.84 | -26.6% | +169.0% | +42.4% | |
| Jan 3, 2022 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 3,800 | $23.07 | $87,666.13 | -60.3% | +1.5% | -60.5% | |
| Dec 1, 2021 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 5,700 | $24.44 | $139,329.60 | -69.5% | -13.4% | -67.9% | |
| Nov 3, 2021 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 5,700 | $24.03 | $136,956.49 | -78.0% | -29.3% | -55.0% | |
| Oct 1, 2021 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 5,700 | $24.83 | $141,505.92 | -100% | -8.3% | -51.1% | |
| Sep 1, 2021 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 5,700 | $26.00 | $148,222.80 | -100% | -6.0% | -42.6% | |
| Aug 2, 2021 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 5,700 | $28.87 | $164,554.44 | -100% | -16.9% | -47.7% |